These compounds, Abacavir Sulfate, Abarelix, and Abiraterone Acetate, each possess unique chemical organizations leading to their varying pharmacological actions. Abacavir Sulfate, a nucleoside reverse transcriptase inhibitor, is readily identified via its molecular formula – C14H15N6O4·H2SO4 – and characteristic luminescent properties observed in techniques such as mass spectrometry and infrared analysis. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor inhibitor, presents with a complex peptide sequence, typically requiring amino acid sequencing and peptide mapping for total identification. Finally, Abiraterone Acetate, a CYP17 inhibitor utilized in prostate malignancy treatment, can be verified through its particular mass and fragmentation patterns acquired through gas chromatography-mass spectrometry (GC-MS) alongside nuclear magnetic resonance (NMR) investigative data, ensuring its correct chemical characterization.
Product: Abacavir Disulfate Sulfate (CAS 188062-50-2) & Associated Compounds
Explore the extensive catalogue detailing Abacavir Sulfate, identified by CAS number 188062-50-2, and a variety of related materials. We provision includes multiple levels to fulfill precise research and ALAMETHICIN 27061-78-5 production needs. Visitors will detailed information including chemical data and available containers options. Furthermore, examine a lineup of structurally cognate substances that could be helpful in the current endeavor. The listing is structured to aid streamlined procurement of high-quality pharmaceutical materials.
Chemical Index: Abarelix and Abirateronum Acetate Registry Codes
For scientists and medicinal professionals needing precise pharmaceutical identification, accurate Registry codes are essential. Specifically, abarelix, a GnRH-releasing hormone modulator used in addressing prostate cancer, is identified the Chemical Abstract Service number 65572-21-8. Furthermore, abiraterone acetate, a powerful medication in metastatic disease, carries the Chemical Abstract Service number 389292-17-3. Thorough notation and validation of these Registry identifiers are imperative to ensure accurate molecule assessment and related procedures. This codes are freely obtainable through multiple research repositories. Always check recognized data for the latest data.
Pharmaceutical Ingredients: Abacavir Sodium Sulfate, Abarelix, Abiraterone Acetate, Registry Identifiers
The identification of key pharmaceutical components often relies on accurate chemical designations. In particular, this article succinctly examines three important instances: Abacavir, a drug reverse polymerase inhibitor; , a gonadotropin-releasing agonist; and Abiraterone, utilized in cancer therapy. These compound is linked with a unique Registry number, offering a universal method for tracking data and ensuring correct exchange within the research industry. Refer the respective repositories for detailed entries and associated records.
Chemical Abstracts Service Number Database: Entries for Abacavir Sulfate, Abarelix, Abiraterone Acetate
The comprehensive Chemical Abstracts Service (CAS) database is an essential resource for researchers and pharmaceutical professionals alike. This section briefly outlines data pertaining to three key medicinal compounds: Abacavir Sulfate, a medication used to manage HIV; Abarelix, a medication utilized in prostate cancer; and Abiraterone Acetate Salt, a potent medication administered in the therapy of metastatic aggressive cancer. Accessing the accurate CAS code for each molecule allows for reliable identification and promotes correct scientific searching. These individual identifiers are vital for data integrity and uniform communication across the field.
Leveraging Web API Substance Data: Item Determination with CAS Numbers
Accurate compound identification is paramount in the material industry, and Web API chemical data provides a robust solution. In particular, CAS numbers act as distinct labels for material substances, allowing effortless consolidation with repositories and frameworks. Such approach furthermore bolsters records quality but also streamlines processes related to investigation, acquisition, and compliance reporting. Furthermore, accessing this information via an Application Programming Interface facilitates optimization and lessens the risk for manual oversight.